UCLH is set to give two more patients treatment for CJD

The University's treatment of Sporadic CJD started in October 2018. The first patient has been receiving treatment for two months and has not experienced any side effects to date. UCLH will now be giving the antibody treatment to a second and third patient.

For further information please visit: https://www.uclh.nhs.uk/News/Pages/TwomoreUCLHpatientstoreceivepioneeringtreatmentforCJD.aspx?fbclid=IwAR32NFzmpCk0DpnDjRGhdvvloRrW9slOcXO88_f04IvLjmkNZ1qxhauY98k